SCHEMBL12469679

SCHEMBL12469679

Nc1ccc(C2C=C(c3ccccc3)CCN2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.39
CYP3A4 P08684 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SIGMAR1 Q99720 1/20 0.36
GID4 Q8IVV7 2/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HTR2C P28335 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
ALOX15 P16050 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PRCP P42785 1/20 0.33
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13987850 0.72 PRCP (0.36) HSD17B10SIGMAR1GID4KMT2AHTR2C
SCHEMBL14095705 0.72 PRCP (0.36) HSD17B10SIGMAR1GID4KMT2AHTR2C
SCHEMBL3653136 0.68 SIGMAR1 (0.42) SIGMAR1RAB9AHTR2CPRCPGAA
SCHEMBL14192246 0.63 CYP3A4 (0.64) HSD17B10CYP3A4TAAR1TDP1NPC1
Biphenyl SCHEMBL3671251 0.62 CYP3A4 (0.93) HSD17B10CYP3A4TAAR1TDP1NPC1
SCHEMBL24524183 0.60 CYP3A4 (1.00) HSD17B10CYP3A4TAAR1TDP1NPC1
Biphenyl-4-Amine SCHEMBL15921057 0.60 CYP3A4 (1.00) HSD17B10CYP3A4TAAR1TDP1NPC1
SCHEMBL21392391 0.60 CYP3A4 (1.00) HSD17B10CYP3A4TAAR1TDP1NPC1
Benzidine SCHEMBL308333 0.60 CYP3A4 (1.00) HSD17B10CYP3A4TAAR1TDP1NPC1
Biphenyl-4-Amine SCHEMBL20296849 0.60 CYP3A4 (1.00) HSD17B10CYP3A4TAAR1TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627651-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2013-08-21 EP disclosed
WO-2012051361-A1 ANTI-VIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-04-19 WO disclosed